ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Hampshire » Internal Medicine

Top Internal Medicine Prescribers in New Hampshire

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN FOTHERGILL M.D.

Internal Medicine

19,871

$1.28M

677
447 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $64

PAUL BERRY MD

Internal Medicine

13,758

$1.01M

652
564 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $64

BORIS NAPRTA MD

Internal Medicine

13,741

$962K

262
220 are 65+

23%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $64

LINDA CRAWFORD M.D.

Internal Medicine

11,958

$732K

280
256 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $64

THOMAS DECKER MD

Internal Medicine

10,463

$608K

489
430 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $64

THOMAS CLAIRMONT MD

Internal Medicine

10,266

$687K

491
442 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $64

DAVID OLKEN D.O.

Internal Medicine

9,519

$537K

429
345 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $64

RONALD WITKIN MD

Internal Medicine

9,435

$573K

576
518 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $64

MAGUED RIZKALLA HANNA MD

Internal Medicine

9,085

$483K

345
285 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $64

DONALD REAPE M.D.

Internal Medicine

8,841

$548K

453
316 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $64

PUSHKALA MURALITHARAN

Internal Medicine

8,715

$545K

306
215 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $64

OLIVER HERFORT MD

Internal Medicine

8,576

$460K

340
248 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $64

ALEXANDER GELLER MD

Internal Medicine

8,036

$496K

356
273 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $64

WENDY MUELLO MD

Internal Medicine

7,966

$639K

333
255 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$80
Average prescription price

Avg: $64

TANJA VANDERLINDE MD

Internal Medicine

7,863

$390K

354
302 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $64

DAVID HALL M.D.

Internal Medicine

7,835

$467K

624
514 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $64

RESTITUTO MALONSO MD

Internal Medicine

7,542

$464K

374
297 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $64

HEIDI ROOT MD

Internal Medicine

7,515

$466K

315
254 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $64

LAWRENCE SANDERS MD

Internal Medicine

7,507

$554K

118
99 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $64

CRAIG MARKERT MD

Internal Medicine

7,380

$356K

200
189 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $64

LUCAS SHIPPEE DO

Internal Medicine

7,369

$485K

472
426 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $64

ROGER GUTNER M.D.

Internal Medicine

7,346

$363K

469
303 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $64

LESLIE REINER M.D.

Internal Medicine

7,253

$522K

307
290 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$72
Average prescription price

Avg: $64

JACINTO CASIO MD

Internal Medicine

6,952

$397K

421
184 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $64

MITCHELL COHEN M.D.

Internal Medicine

6,886

$482K

314
250 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $64

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank